Virtual Medicinal Product (VMP)
-
Glatiramer acetate 20mg powder and solvent for solution for injection vials
Name Details
Current Name
Glatiramer acetate 20mg powder and solvent for solution for injection vials
|
Start Date
21-05-2004
|
End Date
|
Previous Name
Glatiramer acetate 20mg injection vials and diluent
|
Start Date
15-09-2003
|
End Date
20-05-2004
|
|
Abbreviated Name
Glatiramer acetate 20mg inj vials
|
Start Date
01-05-2009
|
|
Glatiramer acetate 20mg pdr & solv for soln for inj vials |
Previous Start Date
08-09-2004
|
Previous End Date
30-04-2009
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Powder and solvent for solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L03AX13
SNOMED Codes
Code
|
Start Date
|
End Date
|
41764111000001105 |
09-05-2023 |
|
400446007 |
26-06-2007 |
08-05-2023 |
134521002 |
15-09-2003 |
25-06-2007 |
VMP Ingredients
Name
Glatiramer acetate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
20.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Glatiramer
-
VMP
(Current) Glatiramer acetate 20mg powder and s...
Virtual Medicinal Product Pack (VMPP) Information